Medical Blogs

Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease • January 21, 2026

Three case reports of human rabies recently appeared in the MMWR. Reading each one served as a reminder of just how horrifying this infection is when it strikes — which very fortunately is quite rare in our country. Two cases were domestic and followed recognized direct bat exposures with no post-exposure preventive measures taken. Here are […] Read More

• Influenza — So Familiar, Still So Mysterious
• How the Z-Pak Took Over Outpatient Medicine, Part 2: The Reckoning
• How the Z-Pak Took Over Outpatient Medicine

Developing Resident Educators • August 19, 2022 • Brandon Temte, DO

We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […] Read More

• Beginnings
• Uncertainty in Medicine — The “July Effect” and Beyond
• 10 Tips for July (and Beyond)

Podcast 301: Monkeypox — what to look for, how to treat • August 19, 2022

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

This time, we look to New York for guidance on recognizing and treating monkeypox.

Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat.

Included below is information for patients as well as links to some key articles of interest to clinicians.

LINKS:

For patients: Dr. Barry Zingman’s “Monkeypox — What you need to know”

For clinicians:

• NEJM article on monkeypox in 16 countries
• NEJM Case Records of the Mass. General Hospital on the state’s first case
• Stephen Baum’s summary of a paper in Emerging Infectious Diseases describing viral persistence on fomites

• Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
• Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
• Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2